SCHEMBL5223383

SCHEMBL5223383

CCNc1cc(C(=O)OC)cc(N2CCCC2=O)c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 2/20 0.47
BACE1 P56817 2/20 0.47
BACE2 Q9Y5Z0 2/20 0.47
CYP2C9 P11712 3/20 0.42
CYP3A4 P08684 1/20 0.42
CASP6 P55212 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 2/20 0.40
HSD17B10 Q99714 1/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 1/20 0.39
MAPT P10636 1/20 0.38
ALDH1A1 P00352 1/20 0.38
USP2 O75604 1/20 0.38
RPS6KB1 P23443 1/20 0.38
AKT1 P31749 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5220855 0.90 CTSD (0.50) CTSDBACE1BACE2CYP2C9CYP3A4
SCHEMBL5218289 0.87 CTSD (0.50) CTSDBACE1BACE2CYP2C9CYP3A4
SCHEMBL5219617 0.81 HSD17B10 (0.50) CYP2C9CYP3A4CASP6TDP1L3MBTL1
SCHEMBL5219544 0.80 CTSD (0.52) CTSDBACE1BACE2CYP2C9CYP3A4
SCHEMBL5222480 0.78 CTSD (0.44) CTSDBACE1BACE2TP53MAPT
SCHEMBL5218030 0.77 BACE1 (0.47) CTSDBACE1BACE2HPGDHSD17B10
SCHEMBL5219674 0.77 CYP2C9 (0.45) CYP2C9CYP3A4L3MBTL1HPGDHSD17B10
SCHEMBL5223591 0.77 CYP2C9 (0.45) CYP2C9CYP3A4CASP6TDP1L3MBTL1
SCHEMBL5226061 0.76 MEN1 (0.48) CYP2C9CYP3A4TDP1L3MBTL1HPGD
SCHEMBL5218025 0.76 BACE1 (0.41) CTSDBACE1BACE2ALDH1A1RPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed